 GoodRx Holdings reported earnings on Monday Feb. 28 that, at least as far as investors were concerned, were not good enough, even as monthly active consumer counts gained double-digit percentages. COVID-19 was a continuing headwind to growth, particularly as concerns prescriptions and refills. 